• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Measurement of perfusion rate in human melanoma xenografts by contrast-enhanced magnetic resonance imaging.

作者信息

Lyng H, Dahle G A, Kaalhus O, Skretting A, Rofstad E K

机构信息

Department of Biophysics, The Norwegian Radium Hospital, Oslo.

出版信息

Magn Reson Med. 1998 Jul;40(1):89-98. doi: 10.1002/mrm.1910400113.

DOI:10.1002/mrm.1910400113
PMID:9660558
Abstract

Reliable methods based on MRI for measurement of the perfusion rate in human tumors are highly warranted. Tumors of two amelanotic human melanoma xenograft lines were subjected to dynamic 1H MRI after i.v. administration of gadopentetate dimeglumine (Gd-DTPA). The aim was to investigate to what extent different perfusion parameters determined from the Gd-DTPA kinetics, i.e., the initial uptake rate, the maximal uptake, the decay rate, and the perfusion rate calculated by use of the Kety equation, can be used as a reliable estimate of tumor perfusion rate. Each parameter was calculated in dual; one calculation was based on relative signal intensity increase (RSII) in T1-weighted MR images and the other on Gd-DTPA concentration determined from the images. The perfusion parameters were compared with the perfusion rates determined from measurement of tumor uptake of 86Rb or [14C]iodoantipyrine. The results showed that reliable estimates of tumor perfusion rate can be achieved from analysis of Gd-DTPA kinetics by use of the Kety equation. Gd-DTPA kinetics based on concentration might be used to achieve reliable estimates of absolute tumor perfusion rate, whereas reliable estimates of the relative perfusion rate might also be achieved from Gd-DTPA kinetics based on RSII. The initial uptake rate, the maximal uptake, and the decay rate of Gd-DTPA, however, are not reliable estimates of tumor perfusion rate, mainly because these parameters are highly influenced by the tumor extracellular volume fraction in addition to the perfusion rate.

摘要

相似文献

1
Measurement of perfusion rate in human melanoma xenografts by contrast-enhanced magnetic resonance imaging.
Magn Reson Med. 1998 Jul;40(1):89-98. doi: 10.1002/mrm.1910400113.
2
Intratumor heterogeneity in blood perfusion in orthotopic human melanoma xenografts assessed by dynamic contrast-enhanced magnetic resonance imaging.通过动态对比增强磁共振成像评估原位人黑色素瘤异种移植瘤中肿瘤内血液灌注的异质性。
J Magn Reson Imaging. 2005 Jun;21(6):792-800. doi: 10.1002/jmri.20321.
3
Assessment of fraction of radiobiologically hypoxic cells in human melanoma xenografts by dynamic contrast-enhanced MRI.通过动态对比增强磁共振成像评估人黑色素瘤异种移植瘤中放射生物学缺氧细胞的比例
Magn Reson Med. 2006 Apr;55(4):874-82. doi: 10.1002/mrm.20852.
4
Assessment of extravascular extracellular space fraction in human melanoma xenografts by DCE-MRI and kinetic modeling.通过动态对比增强磁共振成像(DCE-MRI)和动力学模型评估人黑色素瘤异种移植瘤的血管外细胞外间隙分数
Magn Reson Imaging. 2008 Feb;26(2):160-70. doi: 10.1016/j.mri.2007.06.003. Epub 2007 Aug 9.
5
Assessment of tumor blood perfusion by high-resolution dynamic contrast-enhanced MRI: a preclinical study of human melanoma xenografts.通过高分辨率动态对比增强磁共振成像评估肿瘤血流灌注:人黑色素瘤异种移植的临床前研究
Magn Reson Med. 2004 Aug;52(2):269-76. doi: 10.1002/mrm.20149.
6
Comparison of tumor blood perfusion assessed by dynamic contrast-enhanced MRI with tumor blood supply assessed by invasive imaging.通过动态对比增强磁共振成像评估的肿瘤血流灌注与通过侵入性成像评估的肿瘤血供的比较。
J Magn Reson Imaging. 2005 Mar;21(3):272-81. doi: 10.1002/jmri.20265.
7
Dynamic contrast-enhanced magnetic resonance imaging of human melanoma xenografts with necrotic regions.对具有坏死区域的人黑色素瘤异种移植瘤进行动态对比增强磁共振成像。
J Magn Reson Imaging. 2007 Jul;26(1):133-43. doi: 10.1002/jmri.20939.
8
Fluctuations in tumor blood perfusion assessed by dynamic contrast-enhanced MRI.通过动态对比增强磁共振成像评估肿瘤血流灌注的波动情况。
Magn Reson Med. 2007 Sep;58(3):473-81. doi: 10.1002/mrm.21367.
9
A new method for imaging perfusion and contrast extraction fraction: input functions derived from reference tissues.一种用于灌注成像和对比剂提取分数的新方法:源自参考组织的输入函数。
J Magn Reson Imaging. 1998 Sep-Oct;8(5):1126-34. doi: 10.1002/jmri.1880080519.
10
Assessment of the interstitial fluid pressure of tumors by dynamic contrast-enhanced magnetic resonance imaging with contrast agents of different molecular weights.利用不同分子量的对比剂进行动态对比增强磁共振成像评估肿瘤间质液压力。
Acta Oncol. 2013 Apr;52(3):627-35. doi: 10.3109/0284186X.2012.737931. Epub 2012 Nov 6.

引用本文的文献

1
Vascular normalization in orthotopic glioblastoma following intravenous treatment with lipid-based nanoparticulate formulations of irinotecan (Irinophore C™), doxorubicin (Caelyx®) or vincristine.静脉注射伊立替康(Irinophore C™)、多柔比星(Caelyx®)或长春新碱的脂质纳米粒制剂后,原位脑胶质瘤的血管正常化。
BMC Cancer. 2011 Apr 8;11:124. doi: 10.1186/1471-2407-11-124.
2
Metronomic gemcitabine suppresses tumour growth, improves perfusion, and reduces hypoxia in human pancreatic ductal adenocarcinoma.节拍式吉西他滨抑制人胰腺导管腺癌的肿瘤生长、改善灌注并减少缺氧。
Br J Cancer. 2010 Jun 29;103(1):52-60. doi: 10.1038/sj.bjc.6605727. Epub 2010 Jun 8.
3
Dynamic Contrast Enhanced Magnetic Resonance Imaging in Oncology: Theory, Data Acquisition, Analysis, and Examples.
肿瘤学中的动态对比增强磁共振成像:理论、数据采集、分析及实例
Curr Med Imaging Rev. 2009 May 1;3(2):91-107. doi: 10.2174/157340507780619179.
4
Tumor vascularity assessed by magnetic resonance imaging and intravital microscopy imaging.通过磁共振成像和活体显微镜成像评估肿瘤血管生成。
Neoplasia. 2008 Apr;10(4):354-62. doi: 10.1593/neo.08162.
5
Dynamic contrast-enhanced magnetic resonance imaging rapidly indicates vessel regression in human squamous cell carcinomas grown in nude mice caused by VEGF receptor 2 blockade with DC101.动态对比增强磁共振成像快速显示,在用DC101阻断血管内皮生长因子受体2后,裸鼠体内生长的人鳞状细胞癌出现血管消退。
Neoplasia. 2004 May-Jun;6(3):213-23. doi: 10.1593/neo.3394.
6
Quantitative imaging of tumour blood flow by contrast-enhanced magnetic resonance imaging.通过对比增强磁共振成像对肿瘤血流进行定量成像。
Br J Cancer. 2001 Nov 30;85(11):1655-63. doi: 10.1054/bjoc.2001.2157.